1 Market Overview
1.1 Sheep and Goat Pox Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sheep and Goat Pox Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Sheep and Goat Pox Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Sheep
1.3.3 Goat
1.4 Global Sheep and Goat Pox Vaccines Market Size & Forecast
1.4.1 Global Sheep and Goat Pox Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Sheep and Goat Pox Vaccines Sales in Volume (2017-2028)
1.4.3 Global Sheep and Goat Pox Vaccines Price (2017-2028)
1.5 Global Sheep and Goat Pox Vaccines Production Capacity Analysis
1.5.1 Global Sheep and Goat Pox Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Sheep and Goat Pox Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Sheep and Goat Pox Vaccines Market Drivers
1.6.2 Sheep and Goat Pox Vaccines Market Restraints
1.6.3 Sheep and Goat Pox Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Agrovet
2.1.1 Agrovet Details
2.1.2 Agrovet Major Business
2.1.3 Agrovet Sheep and Goat Pox Vaccines Product and Services
2.1.4 Agrovet Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Biopharma
2.2.1 Biopharma Details
2.2.2 Biopharma Major Business
2.2.3 Biopharma Sheep and Goat Pox Vaccines Product and Services
2.2.4 Biopharma Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Dollvet
2.3.1 Dollvet Details
2.3.2 Dollvet Major Business
2.3.3 Dollvet Sheep and Goat Pox Vaccines Product and Services
2.3.4 Dollvet Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 FGBI – Federal Centre for Animal Health
2.4.1 FGBI – Federal Centre for Animal Health Details
2.4.2 FGBI – Federal Centre for Animal Health Major Business
2.4.3 FGBI – Federal Centre for Animal Health Sheep and Goat Pox Vaccines Product and Services
2.4.4 FGBI – Federal Centre for Animal Health Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Hester Biosciences Limited
2.5.1 Hester Biosciences Limited Details
2.5.2 Hester Biosciences Limited Major Business
2.5.3 Hester Biosciences Limited Sheep and Goat Pox Vaccines Product and Services
2.5.4 Hester Biosciences Limited Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Indian Immunologicals Limited
2.6.1 Indian Immunologicals Limited Details
2.6.2 Indian Immunologicals Limited Major Business
2.6.3 Indian Immunologicals Limited Sheep and Goat Pox Vaccines Product and Services
2.6.4 Indian Immunologicals Limited Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Institut Pasteur d’Algerie
2.7.1 Institut Pasteur d’Algerie Details
2.7.2 Institut Pasteur d’Algerie Major Business
2.7.3 Institut Pasteur d’Algerie Sheep and Goat Pox Vaccines Product and Services
2.7.4 Institut Pasteur d’Algerie Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Intervac (PVT) Ltd.
2.8.1 Intervac (PVT) Ltd. Details
2.8.2 Intervac (PVT) Ltd. Major Business
2.8.3 Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Product and Services
2.8.4 Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 JOVAC
2.9.1 JOVAC Details
2.9.2 JOVAC Major Business
2.9.3 JOVAC Sheep and Goat Pox Vaccines Product and Services
2.9.4 JOVAC Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Tiankang Biopharmacuetical
2.10.1 Tiankang Biopharmacuetical Details
2.10.2 Tiankang Biopharmacuetical Major Business
2.10.3 Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Product and Services
2.10.4 Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Vetal Company
2.11.1 Vetal Company Details
2.11.2 Vetal Company Major Business
2.11.3 Vetal Company Sheep and Goat Pox Vaccines Product and Services
2.11.4 Vetal Company Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Veterinary Research Institute
2.12.1 Veterinary Research Institute Details
2.12.2 Veterinary Research Institute Major Business
2.12.3 Veterinary Research Institute Sheep and Goat Pox Vaccines Product and Services
2.12.4 Veterinary Research Institute Sheep and Goat Pox Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Sheep and Goat Pox Vaccines Breakdown Data by Manufacturer
3.1 Global Sheep and Goat Pox Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Sheep and Goat Pox Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Sheep and Goat Pox Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Sheep and Goat Pox Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Sheep and Goat Pox Vaccines Manufacturer Market Share in 2021
3.5 Global Sheep and Goat Pox Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Sheep and Goat Pox Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Sheep and Goat Pox Vaccines Market Size by Region
4.1.1 Global Sheep and Goat Pox Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Sheep and Goat Pox Vaccines Revenue by Region (2017-2028)
4.2 North America Sheep and Goat Pox Vaccines Revenue (2017-2028)
4.3 Europe Sheep and Goat Pox Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Sheep and Goat Pox Vaccines Revenue (2017-2028)
4.5 South America Sheep and Goat Pox Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Sheep and Goat Pox Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Sheep and Goat Pox Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Sheep and Goat Pox Vaccines Revenue by Type (2017-2028)
5.3 Global Sheep and Goat Pox Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Sheep and Goat Pox Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Sheep and Goat Pox Vaccines Revenue by Application (2017-2028)
6.3 Global Sheep and Goat Pox Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Sheep and Goat Pox Vaccines Sales by Type (2017-2028)
7.2 North America Sheep and Goat Pox Vaccines Sales by Application (2017-2028)
7.3 North America Sheep and Goat Pox Vaccines Market Size by Country
7.3.1 North America Sheep and Goat Pox Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Sheep and Goat Pox Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Sheep and Goat Pox Vaccines Sales by Type (2017-2028)
8.2 Europe Sheep and Goat Pox Vaccines Sales by Application (2017-2028)
8.3 Europe Sheep and Goat Pox Vaccines Market Size by Country
8.3.1 Europe Sheep and Goat Pox Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Sheep and Goat Pox Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Sheep and Goat Pox Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Sheep and Goat Pox Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Sheep and Goat Pox Vaccines Market Size by Region
9.3.1 Asia-Pacific Sheep and Goat Pox Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Sheep and Goat Pox Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Sheep and Goat Pox Vaccines Sales by Type (2017-2028)
10.2 South America Sheep and Goat Pox Vaccines Sales by Application (2017-2028)
10.3 South America Sheep and Goat Pox Vaccines Market Size by Country
10.3.1 South America Sheep and Goat Pox Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Sheep and Goat Pox Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Sheep and Goat Pox Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Sheep and Goat Pox Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Sheep and Goat Pox Vaccines Market Size by Country
11.3.1 Middle East & Africa Sheep and Goat Pox Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Sheep and Goat Pox Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Sheep and Goat Pox Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Sheep and Goat Pox Vaccines
12.3 Sheep and Goat Pox Vaccines Production Process
12.4 Sheep and Goat Pox Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Sheep and Goat Pox Vaccines Typical Distributors
13.3 Sheep and Goat Pox Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
世界の羊痘及び山羊痘ワクチン市場2022年：市場規模予測（～2028年） |
| 【英語タイトル】Global Sheep and Goat Pox Vaccines Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 | |
 | ・商品コード：GIR22DC3927 ・発行会社（調査会社）：GlobalInfoResearch ・発行日：2023年1月 ・ページ数：105 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（注文後2-3日） ・調査対象地域：グローバル ・産業分野：医薬品 |
| Single User（1名様閲覧用） | USD3,480 ⇒換算￥528,960 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD5,220 ⇒換算￥793,440 | 見積依頼/購入/質問フォーム |
| Corporate User（同一法人内共有可） | USD6,960 ⇒換算￥1,057,920 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 羊痘及び山羊痘ワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の羊痘及び山羊痘ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 羊痘及び山羊痘ワクチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・生ワクチン、不活化ワクチン 用途別セグメントは次のように区分されます。 ・羊、山羊 世界の羊痘及び山羊痘ワクチン市場の主要な市場プレーヤーは以下のとおりです。 ・Agrovet、Biopharma、Dollvet、FGBI - Federal Centre for Animal Health、Hester Biosciences Limited、Indian Immunologicals Limited、Institut Pasteur d'Algerie、Intervac (PVT) Ltd.、JOVAC、Tiankang Biopharmacuetical、Vetal Company、Veterinary Research Institute 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、羊痘及び山羊痘ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な羊痘及び山羊痘ワクチンメーカーの企業概要、2019年～2022年までの羊痘及び山羊痘ワクチンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な羊痘及び山羊痘ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別羊痘及び山羊痘ワクチンの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの羊痘及び山羊痘ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での羊痘及び山羊痘ワクチン市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および羊痘及び山羊痘ワクチンの産業チェーンを掲載しています。 ・第13、14、15章では、羊痘及び山羊痘ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 羊痘及び山羊痘ワクチンの概要 - 種類別分析（2017年vs2021年vs2028年）：生ワクチン、不活化ワクチン - 用途別分析（2017年vs2021年vs2028年）：羊、山羊 - 世界の羊痘及び山羊痘ワクチン市場規模・予測 - 世界の羊痘及び山羊痘ワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Agrovet、Biopharma、Dollvet、FGBI - Federal Centre for Animal Health、Hester Biosciences Limited、Indian Immunologicals Limited、Institut Pasteur d'Algerie、Intervac (PVT) Ltd.、JOVAC、Tiankang Biopharmacuetical、Vetal Company、Veterinary Research Institute ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：生ワクチン、不活化ワクチン ・用途別分析2017年-2028年：羊、山羊 ・羊痘及び山羊痘ワクチンの北米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・羊痘及び山羊痘ワクチンのヨーロッパ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・羊痘及び山羊痘ワクチンのアジア市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・羊痘及び山羊痘ワクチンの南米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・羊痘及び山羊痘ワクチンの中東・アフリカ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Sheep and Goat Pox Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Sheep and Goat Pox Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Sheep accounting for % of the Sheep and Goat Pox Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Live Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Sheep and Goat Pox Vaccines include Agrovet, Biopharma, Dollvet, FGBI – Federal Centre for Animal Health, and Hester Biosciences Limited, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Sheep and Goat Pox Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Live Vaccines
Killed Vaccines
Market segment by Application can be divided into
Sheep
Goat
The key market players for global Sheep and Goat Pox Vaccines market are listed below:
Agrovet
Biopharma
Dollvet
FGBI – Federal Centre for Animal Health
Hester Biosciences Limited
Indian Immunologicals Limited
Institut Pasteur d’Algerie
Intervac (PVT) Ltd.
JOVAC
Tiankang Biopharmacuetical
Vetal Company
Veterinary Research Institute
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sheep and Goat Pox Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sheep and Goat Pox Vaccines, with price, sales, revenue and global market share of Sheep and Goat Pox Vaccines from 2019 to 2022.
Chapter 3, the Sheep and Goat Pox Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sheep and Goat Pox Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Sheep and Goat Pox Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sheep and Goat Pox Vaccines.
Chapter 13, 14, and 15, to describe Sheep and Goat Pox Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
❖ レポートの目次 ❖
| ★調査レポート[世界の羊痘及び山羊痘ワクチン市場2022年：市場規模予測（～2028年）] (コード：GIR22DC3927)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の羊痘及び山羊痘ワクチン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせ |
